ODDB.org: Open Drug Database | Medikamente

		Präparat	Zulassungsinhaber	Packungsgrösse	Zusammensetzung	PP	%	SB
FI	PI	Levetiracetam Desitin 250 mg	Desitin Pharma GmbH	30 Tablet(s)	: Levetiracetamum 250 mg	29.20		10%
FI	PI	Levetiracetam-Mepha Teva 250 mg	Mepha Pharma AG	30 Tablet(s)	Coated tablets: Levetiracetamum 250 mg	20.55	-29%	k.A.
FI	PI	Laurak 250 mg	Neuraxpharm Switzerland AG	30	: Levetiracetamum 250 mg	25.55	-12%	10%
FI	PI	Levetiracetam Desitin 250 mg	Desitin Pharma GmbH	30 Tablet(s)	Coated tablets: Levetiracetamum 250 mg	25.55	-12%	10%
FI	PI	Levetiracetam Sandoz 250 mg	Sandoz Pharmaceuticals AG	30 Tablet(s)	Coated tablets: Levetiracetamum 250 mg	25.55	-12%	10%
FI	PI	Levetiracetam Spirig HC 250 mg	Spirig HealthCare AG	30	Coated tablets: Levetiracetamum 250 mg	25.55	-12%	10%
FI	PI	Levetiracetam Zentiva 250mg	Helvepharm AG	30	Coated tablets: Levetiracetamum 250 mg	25.55	-12%	10%
FI	PI	Levetiracetam-Mepha 250 mg	Mepha Pharma AG	30	Coated tablets: Levetiracetamum 250 mg	25.55	-12%	10%
FI	PI	Keppra 250 mg	UCB-Pharma SA	30 Tablet(s)	Coated tablets: Levetiracetamum 250 mg	29.80	+2%	40%
FI	PI	Levetiracetam Rivopharm 250	Rivopharm SA	30	: Levetiracetamum 250 mg	PA		k.A.
FI	PI	Levetiracetam Stada 250 mg	Spirig HealthCare AG	30	Coated tablets: Levetiracetamum 250 mg	PA		k.A.
		Levetiracetam-Neuraxpharm 250 mg	Neuraxpharm Switzerland AG	30	Coated tablets: Levetiracetamum 250 mg	PA		k.A.

Für den Direktvergleich klicken Sie bitte auf den Medikamentennamen im Suchergebnis!

Legende einblenden

2025	©ywesee GmbH